Browse by Phase
Phase 2 / Phase 3 Clinical Trials
Phase 2/3 combined trials bridge efficacy assessment and large-scale comparison, enrolling larger cohorts while still gathering dose-response data.
Total Trials
104
Recruiting Now
104
Top Conditions in Phase 2 / Phase 3
NCT04765020 Phase 2, Phase 3
Recruiting
Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment.
Condition
All Types of Pediatric Cancer
Enrollment
56 pts
Location
Germany
Sponsor
Universität Duisburg-Essen
NCT06096597 Phase 2, Phase 3
Recruiting
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
Condition
Interstitial Cystitis
Enrollment
100 pts
Location
United States
Sponsor
David Sheyn
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial ...
Condition
Metastatic Urothelial Cancer
Enrollment
956 pts
Location
United States, Argentina, Australia
Sponsor
BicycleTx Limited
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06740903 Phase 2, Phase 3
Recruiting
Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic...
Condition
Hemodynamics Instability
Enrollment
140 pts
Location
Pakistan
Sponsor
Sahiwal medical college sahiwa
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT05749302 Phase 2, Phase 3
Recruiting
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-...
Condition
Malignancy
Enrollment
500 pts
Location
China
Sponsor
Cancer Institute and Hospital,
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT04833894 Phase 2, Phase 3
Recruiting
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Ad...
Condition
Generalized Myasthenia Gravis
Enrollment
12 pts
Location
United States, Austria, Belgium
Sponsor
argenx
NCT05519683 Phase 2, Phase 3
Recruiting
Home Transcutaneous Electrical Acustimulation (TEA)
Condition
Irritable Bowel Syndrome With Constipation
Enrollment
160 pts
Location
United States
Sponsor
University of Michigan
NCT06896981 Phase 2, Phase 3
Recruiting
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
Condition
Polycystic Ovary Syndrome (PCOS) Women
Enrollment
30 pts
Location
Bangladesh
Sponsor
Bangabandhu Sheikh Mujib Medic
NCT06155812 Phase 2, Phase 3
Recruiting
Multimodal Vasopressor Strategy in Septic Shock
Condition
Shock, Septic
Enrollment
80 pts
Location
Croatia, Slovenia
Sponsor
University Medical Centre Mari
NCT06785571 Phase 2, Phase 3
Recruiting
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injec...
Condition
Respiratory Insufficiency
Enrollment
204 pts
Location
China
Sponsor
Union Hospital, Tongji Medical
NCT06798363 Phase 2, Phase 3
Recruiting
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatm...
Condition
Infantile Hemangioma
Enrollment
40 pts
Location
China
Sponsor
West China Hospital
NCT05986136 Phase 2, Phase 3
Recruiting
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates...
Condition
Inflammatory Bowel Diseases
Enrollment
50 pts
Location
Egypt
Sponsor
Mostafa Bahaa
NCT03474029 Phase 2, Phase 3
Recruiting
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given D...
Condition
Latent Tuberculosis
Enrollment
3,400 pts
Location
United States, Australia, Canada
Sponsor
Centers for Disease Control an
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07095842 Phase 2, Phase 3
Recruiting
Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic...
Condition
Convulsive Status EPILEPTICUS
Enrollment
668 pts
Location
Egypt
Sponsor
Sohag University
NCT06958627 Phase 2, Phase 3
Recruiting
The Impact of Intelligent Patient Management Model on Medication Adherence of Py...
Condition
HER2 Positive Breast Cancer
Enrollment
964 pts
Location
China
Sponsor
Cancer Institute and Hospital,
NCT06899841 Phase 2, Phase 3
Recruiting
Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block
Condition
Pain Management
Enrollment
90 pts
Location
Egypt
Sponsor
Assiut University
NCT05255653 Phase 2, Phase 3
Recruiting
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Condition
Endometrial Cancer
Enrollment
1,615 pts
Location
Canada, France, Netherlands
Sponsor
Leiden University Medical Cent
NCT03094429 Phase 2, Phase 3
Recruiting
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled...
Condition
Refractory Schizophrenia
Enrollment
287 pts
Location
United States
Sponsor
SyneuRx International (Taiwan)
NCT06214572 Phase 2, Phase 3
Recruiting
Radiation Therapy in Unresectable Gall Bladder Cancer
Condition
Gall Bladder Cancer
Enrollment
249 pts
Location
India
Sponsor
Tata Memorial Centre
NCT07058077 Phase 2, Phase 3
Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children a...
Condition
Heterozygous Familial Hypercholesterolemia (HeFH)
Enrollment
153 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC